NewGenIvf Group (NASDAQ:NIVF) Director Acquires $665,000.00 in Stock

NewGenIvf Group Limited (NASDAQ:NIVF) Director Kong Yiu Cheung purchased 500,000 shares of the stock in a transaction on Thursday, June 18th. The shares were purchased at an average cost of $1.33 per share, with a total value of $665,000.00. Following the transaction, the director owned 1,222,223 shares of the company’s stock, valued at $1,625,556.59. This trade represents a 69.23% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Kong Yiu Cheung also recently made the following trade(s):

• On Monday, July 27th, Kong Yiu Cheung bought 2,500,000 shares of NewGenIvf Group stock. The shares were purchased at an average price of $1.00 per share, with a total value of $2,500,000.00.

NewGenIvf Group Stock Down 3.4%

NIVF opened at $1.14 on Friday. The company has a 50 day moving average of $2.71 and a two-hundred day moving average of $10.90. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group Limited has a 52-week low of $1.11 and a 52-week high of $1,539.00.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.